Application of Circulating Tumor DNA as a Biomarker for Non-Small Cell Lung Cancer

BACKGROUND: Non-small cell lung cancer (NSCLC) is one of the most prevalent causes of cancer-related death worldwide. Recently, there are many important medical advancements on NSCLC, such as therapies based on tyrosine kinase inhibitors and immune checkpoint inhibitors. Most of these therapies requ...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jialiang, Hui, Yan, Zhang, Yanxiang, Zhang, Minghui, Ji, Binbin, Tian, Geng, Guo, Yangqiang, Tang, Min, Li, Lianxing, Guo, Bella, Ma, Tonghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375502/
https://www.ncbi.nlm.nih.gov/pubmed/34422670
http://dx.doi.org/10.3389/fonc.2021.725938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375502/
https://www.ncbi.nlm.nih.gov/pubmed/34422670
http://dx.doi.org/10.3389/fonc.2021.725938

Ejemplares similares